Last quarter (Q4 2022), Novozymes's total revenue was kr4.53B, an increase of 18.13% from the same quarter last year. In Q4, Novozymes's net income was kr883.00M. See Novozymes’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	kr 17.55B	-	kr 17.55B	kr 14.95B	kr 14.01B	kr 14.37B
Cost of Revenue	kr 7.98B	-	kr 7.98B	kr 6.33B	kr 6.16B	kr 6.42B
Gross Profit	kr 9.58B	-	kr 9.58B	kr 8.62B	kr 7.85B	kr 7.95B
Operating Expense	kr 5.15B	-	kr 5.15B	kr 4.74B	kr 4.24B	kr 4.41B
Operating Income	kr 4.43B	-	kr 4.43B	kr 3.88B	kr 3.61B	kr 3.54B
Net Non Operating Interest Income Expense	kr -183.00M	-	kr -183.00M	kr -104.00M	kr -84.00M	kr -25.00M
Other Income Expense	-	-	-	-	-	-
Pretax Income	kr 4.56B	-	kr 4.56B	kr 3.92B	kr 3.52B	kr 3.80B
Tax Provision	kr 870.00M	-	kr 870.00M	kr 779.00M	kr 695.00M	kr 644.00M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	kr 3.68B	-	kr 3.68B	kr 3.15B	kr 2.83B	kr 3.15B
Basic EPS	kr 10.09	-	kr 13.29	kr 11.32	kr 10.07	kr 11.06
Diluted EPS	kr 10.02	-	kr 13.19	kr 11.23	kr 10.02	kr 11.01
Basic Average Shares	kr 830.40M	-	kr 276.64M	kr 277.92M	kr 280.43M	kr 285.11M
Diluted Average Shares	kr 837.30M	-	kr 278.73M	kr 280.23M	kr 282.02M	kr 286.55M
Dividend Per Share	kr 5.50	-	kr 5.50	kr 5.25	kr 5.25	kr 5.00
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	kr 13.13B	-	kr 13.13B	kr 11.07B	kr 10.40B	kr 10.83B
Net Income From Continuing And Discontinued Operation	kr 3.68B	-	kr 3.68B	kr 3.15B	kr 2.83B	kr 3.15B
Normalized Income	kr 3.68B	-	kr 3.64B	kr 2.95B	kr 2.78B	kr 2.87B
Interest Expense	-	-	kr 102.00M	kr 102.00M	kr 63.00M	kr 86.00M
EBIT	kr 4.66B	-	kr 4.66B	kr 4.03B	kr 3.58B	kr 3.88B
EBITDA	kr 4.66B	kr 5.47B	kr 6.12B	kr 5.44B	kr 4.85B	kr 5.07B

Currency in DKK

Novozymes Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing